| 000 | 01821 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516171318.0 | ||
| 264 | 0 | _c20150925 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a0160-6972 | ||
| 024 | 7 |
_a10.1563/AAID-JOI-D-13-00063 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSiebert, Tomas | |
| 245 | 0 | 0 |
_aImmediate Implant Placement in a Patient With Osteoporosis Undergoing Bisphosphonate Therapy: 1-Year Preliminary Prospective Study. _h[electronic resource] |
| 260 |
_bThe Journal of oral implantology _cJul 2015 |
||
| 300 |
_a360-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAlveolar Bone Loss _xclassification |
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xetiology |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDental Implantation, Endosseous _xmethods |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aJaw, Edentulous, Partially _xrehabilitation |
| 650 | 0 | 4 |
_aMandible _xsurgery |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsseointegration _xphysiology |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTooth Extraction |
| 650 | 0 | 4 |
_aTooth Socket _xsurgery |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aJurkovic, Richard | |
| 700 | 1 | _aStatelova, Dagmar | |
| 700 | 1 | _aStrecha, Juraj | |
| 773 | 0 |
_tThe Journal of oral implantology _gvol. 41 Spec No _gp. 360-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1563/AAID-JOI-D-13-00063 _zAvailable from publisher's website |
| 999 |
_c23093327 _d23093327 |
||